The Leadership Team at Target ALS is responsible for setting the strategic vision, guiding the overall direction, and ensuring seamless operations to accelerate ALS drug discovery and development. This team of experts oversees grant distribution, advances translational and clinical research, fosters collaborations, and steers the foundation's scientific and medical policies to drive innovation and progress in ALS treatment.
Andrew Wood
Vp, Clinical Neuroimaging Rese...
Holly Soares
Head Of Precision Medicine, Vp...
Jim Kupiec
Chief Clinical Development Off...
Kenneth Devaney
Chief Operations Officer
Kimberly Scearce - L...
Chief Development Officer,
Manish Raisinghani
CEO
Michael Ahlijanian
Chief Scientific Officer,
Nino Devidze
Vp, Medical,
Rob Scannevin
Chief Scientific Officer,
Yuliya Rzad
Chief Grants Officer
View all